Filing Details
- Accession Number:
- 0000949158-17-000123
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-17 16:31:23
- Reporting Period:
- 2017-11-15
- Accepted Time:
- 2017-11-17 16:31:23
- SEC Url:
- Form 4 Filing
Issuer
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1434715 | A Charles Morreale | C/O Cray Inc., 901 Fifth Avenue, Suite 1000 Seattle WA 98164 | Svp, Field Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-11-15 | 16,797 | $12.08 | 98,007 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-11-15 | 12,972 | $19.28 | 85,035 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-15 | 3,825 | $19.68 | 81,210 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-15 | 21,350 | $19.31 | 59,860 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-11-15 | 4,533 | $19.70 | 55,327 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock option (right to buy) | Disposition | 2017-11-15 | 16,797 | $0.00 | 16,797 | $12.08 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-07-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,059 | Indirect | By 401(k) plan |
Footnotes
- The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.60 to $19.575 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.60 to $19.725 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3).
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.65 to $19.625 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $19.725 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (5).
- The option was 100% vested and exercisable on July 1, 2016